Results 171 to 180 of about 47,865 (277)

Quality of platelet concentrates after three‐day storage following 265 nm ultraviolet C‐light‐emitting diode irradiation

Transfusion Medicine, EarlyView.
Abstract Objectives We aimed to investigate the quality of platelets after storage following irradiation with ultraviolet C (UVC) light‐emitting diodes (LED). Background Controlling transfusion‐related infections, particularly bacterial contamination of platelet concentrates (PCs), is urgently required. UVC‐LEDs have attracted considerable attention as
Tomoya Hayashi, Yoshihiko Sakurai, Yoshihiro Fujimura, Kumiko Oguma, Yuichi Mishima, Fumiya Hirayama, Yoshihiko Tani, Yoshihiro Takihara, Takafumi Kimura   +8 more
wiley   +1 more source

Molecular genetic testing in von Willebrand disease: past, present, and beyond. [PDF]

Haematologica
Seidizadeh O, Lillicrap D.
europepmc   +1 more source

Treatment of von Willebrand disease with FVIII/VWF concentrates.

, 2011
Giancarlo Castaman
openalex   +2 more sources

Dried plasma retains hemostatic function and thermal stability during Arctic military operations

Transfusion, EarlyView.
Abstract Background Dried plasma offers a practical alternative for remote damage control resuscitation, providing hemostatic support and volume replacement. The Arctic presents challenges that necessitate the need for blood‐based resuscitation to extend the “golden hour.” To address this, we evaluated the hemostatic and thermal stability of dried ...
Kanwal Singh, Aron A. Shoara, Henry T. Peng, Viktor Prifti, Katy Moes, Cerys McGuinness, Tristan Bonnici, Maria Shiu, Sushmaa Chandralekha Selvakumar, Peter Andrisani, Pierre‐Marc Dion, Damien Miller, Sebastian Vuong, Colin A. Kretz, Philip J. Wallace, Shawn G. Rhind, Wendy Sullivan‐Kwantes, Andrew N. Beckett   +17 more
wiley   +1 more source

Clinical and laboratory diagnosis of von Willebrand disease. [PDF]

Haematologica
Tosetto A, Eikenboom J.
europepmc   +1 more source

Retention of critical platelet hemostatic functions of amotosalen‐UVA pathogen‐reduced cryoprecipitated fibrinogen complex

Transfusion, EarlyView.
Abstract Background Cryoprecipitate Anti‐Haemophilic Factor (CRYO‐AHF) is enriched for fibrinogen, VWF, FVIII, FXIII and fibronectin, but has short post‐thaw expiration due to risk of transfusion‐transmitted infection (TTI) limiting availability for rapid treatment.
Florian Tupin, Clarisse Mouriaux, Michelle Gatmaitan, Kaja Kaastrup, Subramanian Yegneswaran, Laurence Corash, Pierre H. Mangin   +6 more
wiley   +1 more source

Historical, current and future treatments for von Willebrand disease. [PDF]

Haematologica
Casari C, Leebeek FWG, Peyvandi F.
europepmc   +1 more source

The Relationship Between The Multimeric Structure Of F VIII-VWF And The Facilitation Of Platelet Adhesion To Human Subendothelium (Von Willebrand Factor Activity VWF-A) [PDF]

, 1981
Jan J. Sixma, Kjell S. Sakaríassen, P. A. Bolhuis   +2 more
openalex   +1 more source

von Willebrand factor (VWF) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain. [PDF]

PLoS Comput Biol
Sacco M, Lancellotti S, Ferretti A, Basso M, Di Gennaro L, Castaman G, De Cristofaro R.   +6 more
europepmc   +1 more source